Zimmer Biomet Holdings, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98956P1021
USD
93.16
0.06 (0.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
2,077.30
1,909.10
2,023.20
1,824.20
1,942.00
1,889.20
1,940.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,077.30
1,909.10
2,023.20
1,824.20
1,942.00
1,889.20
1,940.10
Raw Material Cost
767.00
719.90
762.00
700.10
719.30
676.40
702.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
75.80
63.30
59.20
51.30
50.90
50.50
47.60
Selling and Distribution Expenses
809.50
756.70
719.50
705.90
733.70
735.20
708.40
Other Expenses
3.75
4.73
4.92
6.03
5.85
5.74
6.57
Total Expenditure (Excl Depreciation)
1,689.80
1,587.20
1,589.90
1,517.60
1,562.40
1,519.50
1,524.40
Operating Profit (PBDIT) excl Other Income
387.5
321.9
433.29999999999995
306.6
379.6
369.7
415.7
Other Income
28.20
26.30
-17.60
36.60
10.60
13.30
8.10
Operating Profit (PBDIT)
687.50
602.60
679.30
594.10
633.40
621.60
665.00
Interest
75.80
63.30
59.20
51.30
50.90
50.50
47.60
Exceptional Items
-115.30
-55.90
-67.50
-61.60
-37.20
-117.40
-91.80
Gross Profit (PBDT)
1,310.30
1,189.20
1,261.20
1,124.10
1,222.70
1,212.80
1,237.40
Depreciation
271.80
254.40
263.60
250.90
243.20
238.60
241.20
Profit Before Tax
224.60
229.00
289.00
230.30
302.20
215.10
284.40
Tax
71.20
46.50
49.00
-18.90
59.10
42.30
-135.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
152.80
182.00
239.40
249.00
242.80
172.40
419.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
152.80
182.00
239.40
249.00
242.80
172.40
419.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.60
0.60
0.60
0.20
0.30
0.40
0.50
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
153.40
182.60
240.00
249.20
243.10
172.80
419.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
12,525.00
12,395.10
12,468.10
12,374.70
12,741.10
12,598.00
12,480.50
Earnings per share (EPS)
0.77
0.91
1.2
1.23
1.18
0.84
2.01
Diluted Earnings per share
0.77
0.91
1.2
1.23
1.18
0.84
2.01
Operating Profit Margin (Excl OI)
18.65%
16.86%
21.42%
16.81%
19.55%
19.57%
21.43%
Gross Profit Margin
23.9%
25.32%
27.31%
26.38%
28.08%
24.02%
27.09%
PAT Margin
7.36%
9.53%
11.83%
13.65%
12.5%
9.13%
21.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 6.97% vs 3.87% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -36.90% vs 15.82% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 5.86% vs 8.54% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 48.92% vs -0.97% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Zimmer Biomet Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,077.30
983.22
1,094.08
111.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,077.30
983.22
1,094.08
111.28%
Raw Material Cost
767.00
420.93
346.07
82.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
75.80
16.78
59.02
351.73%
Selling and Distribution Expenses
809.50
247.30
562.20
227.34%
Other Expenses
3.75
3.25
0.50
15.38%
Total Expenditure (Excl Depreciation)
1,689.80
717.51
972.29
135.51%
Operating Profit (PBDIT) excl Other Income
387.50
265.71
121.79
45.84%
Other Income
28.20
-16.72
44.92
268.66%
Operating Profit (PBDIT)
687.50
279.44
408.06
146.03%
Interest
75.80
16.78
59.02
351.73%
Exceptional Items
-115.30
16.44
-131.74
-801.34%
Gross Profit (PBDT)
1,310.30
562.29
748.01
133.03%
Depreciation
271.80
30.45
241.35
792.61%
Profit Before Tax
224.60
248.66
-24.06
-9.68%
Tax
71.20
46.31
24.89
53.75%
Provisions and contingencies
0
0
0.00
Profit After Tax
152.80
202.35
-49.55
-24.49%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
152.80
202.35
-49.55
-24.49%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.60
0.00
0.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
153.40
202.35
-48.95
-24.19%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
12,525.00
-258.79
12,783.79
4,939.83%
Earnings per share (EPS)
0.77
9.76
-8.99
-92.11%
Diluted Earnings per share
0.77
9.76
-8.99
-92.11%
Operating Profit Margin (Excl OI)
18.65%
27.02%
0.00
-8.37%
Gross Profit Margin
23.90%
28.39%
0.00
-4.49%
PAT Margin
7.36%
20.58%
0.00
-13.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 207.73 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 8.81% vs -5.64% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.97% vs 3.87% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.34 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -15.99% vs -23.92% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -36.90% vs 15.82% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.93 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 14.40% vs -17.31% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.86% vs 8.54% in Jun 2024

Quarterly - Interest
Interest 7.58 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 19.75% vs 6.93% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 48.92% vs -0.97% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.65%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024